Surmodics, Inc. (SRDX) posted a loss per share of 13 cents in the fourth quarter of fiscal 2024 against the year-ago quarter’s earnings per share (EPS) of 53 cents. The metric beat the Zacks Consensus Estimate of a loss of 27 cents per share by 51.9%.GAAP loss per share for the quarter was 24 cents against the year-ago EPS of 47 cents .Revenues in DetailRevenues of $33.2 million rose 18.8% year over year. The figure surpassed the Zacks Consensus Estimate by 8.3%.The top line gained from solid year-over-year ...